Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML)

著录项

• 来源
  《British Journal of Haematology》 |2010年第1期|p.65-69|共5页
• 作者

  Jim A. Murray; Farhat L. Khanim; Rachel E. Hayden; Charlie F. Craddock; Tessa L. Holyoake; Nick Jackson; Matthew Lumley; Chris M. Bunce; Mark T. Drayson;

  展开▼
• 作者单位

  Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham B15 2TH;

  School of Biosciences, University of Birmingham, Birmingham;

  School of Biosciences, University of Birmingham, Birmingham;

  Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham B15 2TH;

  Section of Experimental Haematology, The University of Glasgow, Glasgow;

  Department of Haematology, University Hospitals Coventry and Warwickshire NHS Trusts, Coventry;

  Department of Haematology, Good Hope Hospital, Sutton Coldfield;

  School of Biosciences, University of Birmingham, Birmingham;

  |Division of Immunity and Infection, University of Birmingham, Birmingham, UK|;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词

  bezafibrate; medroxyprogesterone; toxicity; efficacy; acute myeloid leukaemia;

  机译：苯扎贝特;甲羟孕酮;毒性;疗效;急性髓性白血病;